Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
AffiliationDepartment of Histopathology, Christie Hospital NHS Trust, Manchester, UK. firstname.lastname@example.org
MetadataShow full item record
AbstractAIM: To document the clinical, histological, immunohistochemical and ultrastructural features of three malignant melanomas showing neuroendocrine differentiation. METHODS AND RESULTS: Three patients, two with primary cutaneous melanoma and one with nasal mucosal melanoma, subsequently developing or simultaneously presenting with metastatic malignant melanoma, were studied by conventional histological technique, immunohistochemistry of formalin-fixed paraffin-wax embedded tissues, and electron microscopy of epoxy-resin-embedded tumour tissue. Tumours showed either small cell or conventional malignant melanoma cell morphology. One of the three primary melanocytic lesions (the nasal melanoma) exhibited neuroendocrine differentiation immunohistochemically. All three metastatic malignant melanomas showed, in varying combinations, immunohistochemical and ultrastructural evidence for neuroendocrine differentiation: they were positive for the melanocytic markers, S100 protein, HMB-45, Melan-A and tyrosinase, and the neuroendocrine markers chromogranin, synaptophysin and neurofilament protein. Ultrastructural study in two of the metastases revealed neuroendocrine granules but no lattice-bearing melanosomes. CONCLUSIONS: The cases described are the most comprehensively investigated malignant melanomas showing neuroendocrine differentiation to date, and the first to document neuroendocrine differentiation ultrastructurally in these tumours. Malignant melanoma with neuroendocrine differentiation therefore needs to be recognized among the other, better known variants of malignant melanoma.
CitationMalignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases. 2005, 47 (4):402-9 Histopathology
- HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
- Authors: Yu CH, Chen HH, Liu CM, Jeng YM, Wang JT, Wang YP, Liu BY, Sun A, Chiang CP
- Issue date: 2005 Oct
- Rhabdomyosarcomatous (myoblastic?) phenotype of metastatic malignant melanoma. A case report.
- Authors: Pasz-Walczak G, Jesionek-Kupnicka D, Kubiak R, Biernat W, Sygut J, Kordek R
- Issue date: 2002
- Immunohistochemical spectrum of malignant melanoma. The common presence of keratins.
- Authors: Miettinen M, Franssila K
- Issue date: 1989 Dec
- Rhabdomyoblastic differentiation in malignant melanoma in adults: report of 2 cases.
- Authors: Gharpuray-Pandit D, Coyne J, Eyden B, Banerjee SS
- Issue date: 2007 Jan
- HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
- Authors: Gleason BC, Nascimento AF
- Issue date: 2007 Feb